Published in J Neurosci on August 27, 2008
The dynamic effects of nicotine on the developing brain. Pharmacol Ther (2009) 3.01
Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet (2009) 2.35
Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron (2012) 1.81
Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J (2009) 1.68
Molecular mechanisms underlying behaviors related to nicotine addiction. Cold Spring Harb Perspect Med (2013) 1.28
The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci (2010) 1.19
Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harb Perspect Med (2012) 1.17
Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors. Cereb Cortex (2012) 1.11
Nicotinic modulation of cortical circuits. Front Neural Circuits (2014) 1.09
Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol (2009) 1.06
Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through α4/β2/α5 nicotinic acetylcholine receptors. Neuropsychopharmacology (2010) 1.04
Nicotinic α5 subunits drive developmental changes in the activation and morphology of prefrontal cortex layer VI neurons. Biol Psychiatry (2011) 0.94
Molecules and circuits involved in nicotine addiction: The many faces of smoking. Neuropharmacology (2013) 0.94
Cholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activity. Front Neural Circuits (2014) 0.94
Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors. Front Synaptic Neurosci (2014) 0.89
The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy. Front Physiol (2015) 0.88
Developmental sex differences in nicotinic currents of prefrontal layer VI neurons in mice and rats. PLoS One (2010) 0.87
Nicotine exposure during adolescence leads to short- and long-term changes in spike timing-dependent plasticity in rat prefrontal cortex. J Neurosci (2012) 0.86
Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors. J Neurophysiol (2015) 0.85
Modulation of high- and low-frequency components of the cortical local field potential via nicotinic and muscarinic acetylcholine receptors in anesthetized mice. J Neurophysiol (2013) 0.83
Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of α5 or β2 subunits. J Neurosci (2011) 0.83
Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex. Cell Mol Life Sci (2014) 0.82
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia. Neuropharmacology (2013) 0.82
Cholinergic excitation in mouse primary vs. associative cortex: region-specific magnitude and receptor balance. Eur J Neurosci (2014) 0.82
DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory. PLoS One (2014) 0.80
Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease. J Neurosci (2015) 0.78
Chrna5 genotype determines the long-lasting effects of developmental in vivo nicotine exposure on prefrontal attention circuitry. Neuropharmacology (2013) 0.78
Impaired auditory discrimination learning following perinatal nicotine exposure or β2 nicotinic acetylcholine receptor subunit deletion. Behav Brain Res (2012) 0.78
Neuronal nicotinic receptors in sleep-related epilepsy: studies in integrative biology. ISRN Biochem (2012) 0.76
α4β2(∗) nicotinic receptors stimulate GABA release onto fast-spiking cells in layer V of mouse prefrontal (Fr2) cortex. Neuroscience (2016) 0.75
Layer-specific cholinergic control of human and mouse cortical synaptic plasticity. Nat Commun (2016) 0.75
Developmental Ethanol Exposure Leads to Long-Term Deficits in Attention and Its Underlying Prefrontal Circuitry. eNeuro (2016) 0.75
Dendritic spine density of prefrontal layer 6 pyramidal neurons in relation to apical dendrite sculpting by nicotinic acetylcholine receptors. Front Cell Neurosci (2015) 0.75
Sustained Attentional States Require Distinct Temporal Involvement of the Dorsal and Ventral Medial Prefrontal Cortex. Front Neural Circuits (2016) 0.75
α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion. Dev Neurobiol (2011) 0.75
Nicotinic regulation of experience-dependent plasticity in visual cortex. J Physiol Paris (2016) 0.75
Serotonergic Suppression of Mouse Prefrontal Circuits Implicated in Task Attention. eNeuro (2016) 0.75
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet (2006) 13.16
Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry (2008) 6.73
Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry (2008) 6.37
Grouping of brain rhythms in corticothalamic systems. Neuroscience (2005) 5.21
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron (2002) 3.78
Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol (1995) 3.37
Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol (2004) 3.27
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (1995) 3.15
Cholinergic switching within neocortical inhibitory networks. Science (1998) 2.64
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry (2006) 2.53
Desensitization of neuronal nicotinic receptors. J Neurobiol (2002) 2.49
The maternal and fetal physiologic effects of nicotine. Semin Perinatol (1996) 2.43
alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol (2006) 2.42
Cognitive effects of nicotine. Biol Psychiatry (2001) 2.41
Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci (2003) 2.35
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci (1992) 2.29
The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry (2007) 2.19
Roles of accessory subunits in alpha4beta2(*) nicotinic receptors. Mol Pharmacol (2008) 2.18
Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature (1996) 2.06
The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol (2003) 2.00
Postnatal growth and morphological development of the brain: a species comparison. Birth Defects Res B Dev Reprod Toxicol (2006) 1.95
Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors. Mol Pharmacol (2006) 1.91
Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend (1993) 1.84
At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby? Early Hum Dev (1991) 1.79
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet (2000) 1.73
Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron (2007) 1.72
Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? J Child Psychol Psychiatry (2005) 1.71
Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr (2005) 1.69
The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system. Brain Res (1990) 1.68
Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. J Neurochem (2007) 1.57
Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berl) (2005) 1.51
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry (2001) 1.44
Executive and social behaviors under nicotinic receptor regulation. Proc Natl Acad Sci U S A (2003) 1.44
Nicotinic control of axon excitability regulates thalamocortical transmission. Nat Neurosci (2007) 1.40
Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience (2004) 1.35
Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J Neurosci (2005) 1.31
Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. Eur J Neurosci (1999) 1.25
Excitatory connections made by presynaptic cortico-cortical pyramidal cells in layer 6 of the neocortex. Cereb Cortex (2005) 1.25
Layer 6 cortico-thalamic pyramidal cells preferentially innervate interneurons and generate facilitating EPSPs. Cereb Cortex (2005) 1.25
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat (2001) 1.20
Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther (1989) 1.13
Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. J Am Acad Child Adolesc Psychiatry (2006) 1.11
Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats. Eur J Neurosci (2006) 1.11
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain (2006) 1.11
Expression of alpha5 nicotinic acetylcholine receptor subunit mRNA during hippocampal and cortical development. J Comp Neurol (2005) 1.11
Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res (2001) 1.09
Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function. Proc Natl Acad Sci U S A (2005) 1.08
Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res (2004) 1.08
Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. J Neurosci (2003) 1.05
Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat (2000) 1.03
The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem Pharmacol (2007) 1.01
Sleep oscillations developing into seizures in corticothalamic systems. Epilepsia (2003) 0.93
Attention-deficit/hyperactivity disorder: a plausible mouse model? Acta Paediatr (2006) 0.91
The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain. Brain Res Mol Brain Res (1999) 0.80
Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene. Epilepsia (2007) 0.79
Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med (2011) 2.05
The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci (2010) 1.19
Severe deficits in 5-HT2A -mediated neurotransmission in BDNF conditional mutant mice. J Neurobiol (2006) 1.18
Layer II/III of the prefrontal cortex: Inhibition by the serotonin 5-HT1A receptor in development and stress. J Neurosci (2009) 1.07
Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on L-tryptophan and tryptophan hydroxylase-activating kinases. Eur J Neurosci (2005) 1.00
Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability. J Neurosci (2010) 0.96
Nicotinic α5 subunits drive developmental changes in the activation and morphology of prefrontal cortex layer VI neurons. Biol Psychiatry (2011) 0.94
Developmental sex differences in nicotinic currents of prefrontal layer VI neurons in mice and rats. PLoS One (2010) 0.87
Enhanced prefrontal serotonin 5-HT(1A) currents in a mouse model of Williams-Beuren syndrome with low innate anxiety. J Neurodev Disord (2010) 0.85
Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of α5 or β2 subunits. J Neurosci (2011) 0.83
Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex. Cell Mol Life Sci (2014) 0.82
Cholinergic excitation in mouse primary vs. associative cortex: region-specific magnitude and receptor balance. Eur J Neurosci (2014) 0.82
The native serotonin 5-HT(5A) receptor: electrophysiological characterization in rodent cortex and 5-HT(1A)-mediated compensatory plasticity in the knock-out mouse. J Neurosci (2012) 0.79
Mice with compromised 5-HTT function lack phosphotyrosine-mediated inhibitory control over prefrontal 5-HT responses. J Neurosci (2014) 0.78
Perspective: Translational studies on glutamate and dopamine neurocircuitry in addictions: implications for addiction treatment. Neuropsychopharmacology (2008) 0.75